Hemodynamic management using CardioMEMS
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $81,715 | 25 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $81,715 | 25 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF) | Abbott Laboratories | $81,715 | 0 |
Top Doctors Receiving Payments for Hemodynamic management using CardioMEMS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $81,715 | 25 |
Manufacturing Companies
- Abbott Laboratories $81,715
Product Information
- Type Device
- Total Payments $81,715
- Total Doctors 0
- Transactions 25
About Hemodynamic management using CardioMEMS
Hemodynamic management using CardioMEMS is a device associated with $81,715 in payments to 0 healthcare providers, recorded across 25 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2018. In 2018, $81,715 was paid across 25 transactions to 0 doctors.
The most common payment nature for Hemodynamic management using CardioMEMS is "Unspecified" ($81,715, 100.0% of total).
Hemodynamic management using CardioMEMS is associated with 1 research study, including "INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF)" ($81,715).